🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥 Much awaited- SANO trial published (Phase 3, non-inferiority trial, 🇳🇱) 309 patients with esophageal cancer with complete response after neoadjuvant chemoradiation (EUS, biopsy, PET) ➡️198 active surveillance, 111 standard surgery. ‼️74% adenocarcinoma 🕰️ Median follow-up

Congrats, welcome to the NW Gen Surg Residents family!

DOS Research Conference is tomorrow at 9 am! Darlene Ratliff will explain how extramural grant proposals are handled by DOS Research Administration. Jessie Ho and Saieesh Rao will share how they balanced clinical residency with grant planning and preparation! Northwestern Surgery

Megan Perez will give tomorrow's DOS Research INSIGHT Talk on her work with Chad Purnell in pediatric plastic surgery! Northwestern Surgery Shriners Children's

Had a great time at the American College of Surgeons Residents as Teachers and Leaders Course this past weekend Energizing to be around so many fellow residents interested in improving #SurgEd for ourselves and others #RATL2025

Join us Thursday, May 17 for the Northwestern Surgery Research Conference Toolkit Lecture. Presenter will be Joseph Feinglass, PhD. Moderator will be Karen J. Ho, MD . vinay prabhakran

Join us for Dr. Joe Feinglass's DOS Research Toolkit Lecture TOMORROW, 4/17/25, at 9 am! NQUIRES

📢Applications are now live for our Michael Zinner HSR Fellowship Program ! ▶️1 yr research fellowship for trainees and junior faculty ▶️Fellow is matched with an SOC faculty member to develop and execute a project ▶️$2K for research-related travel expenses

Join us Thursday, May 8 starting at 9am for the Northwestern Surgery Research Conference Insight Presentations. Presenters will be Saieesh Rao Paola Barrios, MD and Lara Lopes, MD. Moderator will be Raheem Bell, M.D.

Don't miss the next DOS Research Toolkit Lecture on Thursday, 5/15/25, 9-10 am! We are thrilled to welcome back an alumni panel to discuss early career surgical practice! Northwestern Surgery

Remarkable results for neoadj chemo-immunotherapy in locally advanced, N2/N3, lung cancer. 75% curative resections w v high pCR. Notably >40% of pts treated had high PD-L1 (unselected would be ~25-30%) but the boundary for lung surgery continues to chase the horizon #LCSM

🔥 Final analysis: CheckMate 577 Adjuvant nivolumab in resected stage II/III EC/GEJC post-CRT & surgery ✅ DFS benefit maintained 21.8 vs 10.8 mo HR 0.76 (95% CI 0.63–0.91) 🧠 DMFS improved 27.3 vs 14.6 mo HR 0.75 (95% CI 0.62–0.90) ⚠️ OS not statistically significant 51.7 vs

☑️#ASCO25 Abstract🆙 ☑️#LCSM Oral, LocReg/SCLC 🔥NeoADAURA: Neoadjuvant osimertinib ± chemotherapy (CT) vs CT alone in resectable epidermal growth factor receptor-mutated NSCLC 🎙️ Jamie Chaft 🎯Osi+CT / Osi / PBO+CT: MPR 26%/25%/2%, pCR 4%/9%/0% OncoAlert ASCO

As we are heading for the ASCO-2025, here's a preview of top lung cancer trials, most discussed among oncologists on X, highlighted by LARVOL CLIN. Get the latest #ASCO25 updates: t.ly/7TCD6 #LARVOL #LungCancer #CancerResearch #Oncology #ClinicalTrials

Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results:

So you've heard the practice changing exercise CHALLENGE trial! But what did that groundbreaking exercise program actually look like day-to-day? Let's explore the "Structured Exercise Program" based on info from their paper supplement on NEJM #ASCO2025 #ASCO25 1/10

Landmark OS data from #CheckMate816 just dropped in NEJM! 🫁 Neoadjuvant #Nivolumab + chemo in resectable #NSCLC delivers: ✅ 5-yr OS: 65.4% vs 55.0% ✅ HR: 0.72 (p=0.048) ✅ Lung cancer–specific survival HR: 0.65 ✅ OS with pCR: 95.3% ✅ ctDNA clearers: 75%+ OS 📌 No lung

This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.

Join us Thursday, June 12 at 9am for the Northwestern Surgery Research Conference INSIGHT Presentations. We'll hear from Daniel Liesman, MD, Nicole Ontiveros, MD and John Rode, MD, MS. All moderated by Lara Lopes, MD MS.

So excited for the 6th Annual William H. Pearce, MD Research Symposium tomorrow, showcasing the research done by our amazing trainees this year, a talk by Edelstone-Bendix Visiting Professor @laparoscopes, and the graduating chiefs residents!